NCT07334834 Implementation of an Algorithm- and Multi-professional Team-supported Strategy to Improve Lipid Management of Patients With Atherosclerotic Cardiovascular Disease
| NCT ID | NCT07334834 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Colorado Prevention Center |
| Condition | Hyperlipidemia |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-12-10 |
| Primary Completion | 2027-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-12-10 with a primary completion date of 2027-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a randomized, controlled, collaborative, multicenter, pilot implementation science study evaluating the hypothesis that algorithm- and multi-professional team-supported lipid management reduces low density lipoprotein-cholesterol (LDL-C) compared with usual care in patients with atherosclerotic cardiovascular disease (ASCVD).
Eligibility Criteria
Inclusion Criteria: * Provided informed consent * Age \>18 years inclusive at screening * Documented atherosclerotic vascular disease including: * Coronary artery disease (prior revascularization, myocardial infarction, imaging evidence of coronary atherosclerosis) * Peripheral artery disease (prior revascularization, amputation, ankle: brachial index (ABI) ≤ 0.90, imaging evidence of extra-coronary atherosclerosis) * Carotid artery disease (prior endarterectomy or stenting of the extracranial carotid artery or imaging evidence of carotid atherosclerosis) * Imaging evidence of atherosclerotic vascular disease in a non-coronary vascular bed (e.g. aorta, mesenteric, renal) * LDL-C \>70mg/dL Exclusion Criteria: * Any reason that, in the opinion of the investigator, the patient would be unable to adhere to the protocol for the duration of the study (e.g. terminal diagnosis, metastatic cancer) or in whom participation might result in harm. * Planned active titration of current lipid-lowering therapy * Myocardial infarction or arterial revascularization within prior 30 days
Contact & Investigator
Marc Bonaca, MD
PRINCIPAL INVESTIGATOR
Colorado Prevention Center
Frequently Asked Questions
Who can join the NCT07334834 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hyperlipidemia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07334834 currently recruiting?
Yes, NCT07334834 is actively recruiting participants. Contact the research team at info@cpcmed.org for enrollment information.
Where is the NCT07334834 trial being conducted?
This trial is being conducted at Aurora, United States.
Who is sponsoring the NCT07334834 clinical trial?
NCT07334834 is sponsored by Colorado Prevention Center. The principal investigator is Marc Bonaca, MD at Colorado Prevention Center. The trial plans to enroll 100 participants.